Nightstar Therapeutics

Nightstar Therapeutics

Biogen to buy Nightstar Therapeutics in a $800 million cash dealПодробнее

Biogen to buy Nightstar Therapeutics in a $800 million cash deal

Radical new gene therapy restores sight to patients with rare eye condition - BBC NewsПодробнее

Radical new gene therapy restores sight to patients with rare eye condition - BBC News

Innovation Conversations: Guiding Nightstar with Professor Robert MacLarenПодробнее

Innovation Conversations: Guiding Nightstar with Professor Robert MacLaren

National Chapter Vision Seminar | Clinical TrialsПодробнее

National Chapter Vision Seminar | Clinical Trials

Seeing the future of gene therapy: How does it work?Подробнее

Seeing the future of gene therapy: How does it work?

RNA-Based Therapeutics With Nutcracker Therapeutics' Dr. Geoff NosratiПодробнее

RNA-Based Therapeutics With Nutcracker Therapeutics' Dr. Geoff Nosrati

Syncona launches new gene therapy company Beacon TherapeuticsПодробнее

Syncona launches new gene therapy company Beacon Therapeutics

Nightstar Taking Many Shots at Retinal DiseaseПодробнее

Nightstar Taking Many Shots at Retinal Disease

3.5 Eyes on the prize: Developing therapies for ophthalmic diseaseПодробнее

3.5 Eyes on the prize: Developing therapies for ophthalmic disease

Spinout Spotlights - Robert MacLaren, Professor of Ophthalmology, University of OxfordПодробнее

Spinout Spotlights - Robert MacLaren, Professor of Ophthalmology, University of Oxford

Retinitis Pigmentosa and X-linked Retinitis Pigmentosa featuring Beacon TherapeuticsПодробнее

Retinitis Pigmentosa and X-linked Retinitis Pigmentosa featuring Beacon Therapeutics

Gene Therapy for Inherited Retinal DiseasesПодробнее

Gene Therapy for Inherited Retinal Diseases

Commensal Virus Vectors With Ring Therapeutics' Tuyen Ong, M.D.Подробнее

Commensal Virus Vectors With Ring Therapeutics' Tuyen Ong, M.D.

Journal Club | Developing Retinal Gene Therapy for Zellweger Spectrum Disorder (ZSD)Подробнее

Journal Club | Developing Retinal Gene Therapy for Zellweger Spectrum Disorder (ZSD)

Advances in gene therapyПодробнее

Advances in gene therapy

4D Molecular TherapeuticsПодробнее

4D Molecular Therapeutics

Prof Robert MacLaren at RCOphth 2019Подробнее

Prof Robert MacLaren at RCOphth 2019

RPGRIP1 Gene Therapy Program- May 2023 Community Q&AПодробнее

RPGRIP1 Gene Therapy Program- May 2023 Community Q&A